Company intelligence / Profile preview
Ginwa Enterprise Group
- Ownership
- Private
- Employees
- ~588
- Development stage
- Other
Overview
Ginwa Enterprise Group develops and sells a broad portfolio of pharmaceuticals in China across multiple therapeutic areas. Products are available in various dosage forms including tablets and syrups. The company operates at commercial scale with significant annual revenues.
- Therapeutic areas
- Women's HealthImmunologyOtherRheumatologyGastroenterologyCardiovascularInfectious Diseases
- Modalities
- Small moleculeTraditional Chinese medicine (herbal/plant-based products)Biologic
- Industry
- Biotech
Drug pipeline
10 assets9 more assets in the full pipeline.
Beyond the preview
Go deeper on Ginwa Enterprise Group.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ginwa Enterprise Group.